InvestorsHub Logo
Followers 11
Posts 344
Boards Moderated 0
Alias Born 02/01/2011

Re: FlyFishingStocks post# 314906

Sunday, 12/13/2020 9:49:40 PM

Sunday, December 13, 2020 9:49:40 PM

Post# of 426688
If you read this comprehensive highly powered study by the WHO you will find out that there is no statistically significant clinical benefit in terms of survival etc. when Remdesivir is administered but serious side effects like kidney and heart damage .

https://www.nejm.org/doi/full/10.1056/NEJMoa2023184?query-featured_coronavirus=
??https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/0/nejm.ahead-of-print/nejmoa2023184/20201202/images/img_medium/nejmoa2023184_f2.jpeg
https://theprint.in/opinion/who-advice-on-remdesivir-is-a-warning-for-covid-19-vaccines/549120/

https://www.thehealthsite.com/news/who-warns-against-remdesivir-for-covid-19-treatment-781465/

It does not serve AMARIN to be associated with this potentially toxic function whereas VASCEPA is 100% safe in contrast as we all know
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News